| 书目名称 | Hypofractionated and Stereotactic Radiation Therapy |
| 副标题 | A Practical Guide |
| 编辑 | Orit Kaidar-Person,Ronald Chen |
| 视频video | http://file.papertrans.cn/431/430774/430774.mp4 |
| 概述 | Easily accessible handbook that summarizes published data on efficacy of different dose fractionations and the dose/volume/outcome data for relevant normal tissues and organs under different fractiona |
| 图书封面 |  |
| 描述 | This handbook summarizes the data and techniques for hypofractionation and stereotactic radiation in a clinically-accessible way. Hypofractionated radiation therapy, which consists of larger-dose radiation treatments that are given over a shorter time period compared to conventional radiation fraction sizes, is used to treat a variety of cancers, including prostate, breast, lung, and colorectal. Conventional radiation therapy and hypofractionated radiation therapy have different effectiveness rates for cancer treatment and have different impacts on normal tissues in terms of causing toxicity. There is a significant and growing body of literature on the use of different dosing regimens to treat a variety of cancers and radiation oncologists need to keep up with the various dosing schedules, the effect of each regimen on cancer control in different cancers, and how the different schedules affect each organ in terms of toxicity. The book thus provides concise information ranging from commonly-used dose-fractionation schemes for hypofractionated and stereotactic body radiotherapy to simulation and treatment specifications to published safety and efficacy data. Chapters additionally e |
| 出版日期 | Book 20181st edition |
| 关键词 | dose response; efficacy of dose fractionations; hypofractionated radiation therapy; normal tissue toler |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-92802-9 |
| isbn_softcover | 978-3-319-92800-5 |
| isbn_ebook | 978-3-319-92802-9 |
| copyright | Springer International Publishing AG, part of Springer Nature 2018 |
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-5 05:50
发表于 2025-3-21 17:57:21
